BUY Biocon Ltd — Prakash Gaba

Biocon share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Intraday)18 Aug 2026, 10:01 am ISTvia CNBC Awaaz.

Entry₹419.7Inferred
Target₹425
Total upside +1.26% (call closed)
Stop loss₹415-1.12% risk
At expiry₹419.718 Aug 2026, 3:05 pm
Expired0.00%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Aug 2026
2 supporting1 opposing
Supports the BUY call (2)

Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector

NewsEt-Markets·18 Aug · today

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·18 Aug · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.